Provided are compositions, transgenic animals and methods for screening and analyzing drugs for toxicity and clearance. Such methods include creating a transgenic animal that lacks expression of two or more slc22 family member--organic ion transporters. Further disclosed are methods useful in determining a subjects sensitivity and a drugs efficacy based upon single nucleotide length polymorphisms in organic ion transport genes.